Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"Intravesical therapy"”.
-
Developments in intravesical therapy for non-muscle invasive bladder cancer.
RU Radboud Universiteit Nijmegen, 29 september 2009
-
An Epidemiology Study of Prognositic Factors for Non-Muscle Invasive Bladder Cancer
… on the stage and grade of the cancer, an intravesical therapy may be followed. Intravesical therapy with Bacillus Calmette-Guerin (BCG) after TURBT is the gold standard therapy to prevent or delay recurrence/progression, but it has a 20-40% failure rate and various adverse effects. …
-
The investigation of the properties and behaviour of superficial bladder cancer by an in vitro explant tumour system, and its use in the response to conventional and novel intravesical cytotoxic agents /cTimothy John Crook.
… for the assessment of therapeutic agents used as intravesical therapy, and which is consistent and amenable to rationalised experiments.</p> <p><i>Introduction:</i> Superficial transitional cell carcinoma of the bladder is more common compared to the invasive type, but has a high probability of …
-
Μορφολογική εκτίμηση της λειτουργικής διαντιδράσης (cross talk) των υποδοχέων οιστρογόνων τύπου β (ERβ) και του μεταγραφικού παράγοντα NFkB κατά την καρκινογένεση, στα νεοπλάσματα από μεταβατικό επιθήλιο της ουροδόχου κύστεως: Στόχος: πιθανή εφαρμογή στη χημειοπρόληψη
… of the patients had received any preoperative intravesical therapy. Bladder tumors were graded and staged according to the World Health Organization (WHO) grading. Paraffin section immunohistochemistry was utilized and relative expression was estimated in intracellular compartments, …
-
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
… prognosis and is treated by tumor resection and intravesical therapy, whereas muscle-invasive BC has poor prognosis and requires radical cystectomy combined with cisplatin-based chemotherapy. High- throughput sequencing technologies allow identification of individual molecular signatures to …
-
Η επίδραση των ενδοκυστικών εγχύσεων επιρουμπικίνης και ιντερφερόνης α - 2b στα κύτταρα του ανοσοποιητικού συστήματος στο τοίχωμα της ουροδόχου κύστης
Objective: To investigate the effect of intravesical instillations of epirubicin and interferon a-2b, alone or in combination upon the numbers of immune cells in the bladder wall. As far as the combination is concerned we investigated the hypothesis that epirubicin might facilitate the action of …
-
Mechanisms of action of Manuka honey as a potential therapeutic agent for bladder pain syndrome/interstitial cystitis: clinical and laboratory studies
… properties. Thus, it might be a useful adjuvant therapy for BPS/IC. The aims of this study were to investigate the link between neurogenic inflammation in the pathophysiology of BPS/IC and explore the potential anti-inflammatory effects of Medihoney and Manuka honey extract on inhibiting mast …
-
BCG therapy for upper urothelial carcinoma. literature review /
… and examine bacillus Calmuette-Guerin (BCG) therapy, it’s history, mechanism and how it relates to the treatment of upper urothelial carcinoma. The information collected in this review should aid in the understanding of upper urothelial carcinoma as well as BCG therapy and how BCG therapy …
-
Αξιολόγηση της έκφρασης βιολογικών δεικτών σε ασθενείς με επιφανειακό καρκίνο της ουροδόχου κύστης υπό συμπληρωματική ενδοκυστική θεραπεία
This study investigates whether the use of intravesical treatment regimes affects biomarkers CD10, Her2, Ki67, p53, E-cadherin, B-catenin in superficial bladder cancer. The 6 tumour markers were studied in the biopsy material of the 1st TUR-BT and 2nd TUR-BT respectively. All of these studies were …